标题
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
作者
关键词
-
出版物
JACC-Heart Failure
Volume 9, Issue 8, Pages 578-589
出版商
Elsevier BV
发表日期
2021-07-27
DOI
10.1016/j.jchf.2021.04.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2021) Tamique Mason et al. JACC-Cardiovascular Imaging
- A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
- (2021) Shigenori Hiruma et al. Cardiovascular Diabetology
- Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease
- (2021) Salva R. Yurista et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure
- (2020) Valentina Parisi et al. Frontiers in Physiology
- Inflammation in Heart Failure
- (2020) Sean P. Murphy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Twenty-First Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
- (2020) Ian J. Neeland et al. JACC-Cardiovascular Imaging
- Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
- (2020) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
- (2020) Carlos G. Santos-Gallego et al. JACC-Cardiovascular Imaging
- Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
- (2019) Carlos G. Santos-Gallego et al. CARDIOVASCULAR DRUGS AND THERAPY
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin’s Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes
- (2019) Fumika Shigiyama et al. Diabetes Therapy
- Myocardial Tissue Characterization and Fibrosis by Imaging
- (2019) Theodoros D. Karamitsos et al. JACC-Cardiovascular Imaging
- Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk
- (2019) Alexandra C. Villasante Fricke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients with Type 2 Diabetes Mellitus
- (2019) Jung-Chi Hsu et al. Scientific Reports
- Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis
- (2019) Eric Y. Yang et al. Circulation-Cardiovascular Imaging
- Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors
- (2019) Adina Braha et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The effect of dapagliflozin treatment on epicardial adipose tissue volume
- (2018) Takao Sato et al. Cardiovascular Diabetology
- The optimal anatomic site for a single slice to estimate the total volume of visceral adipose tissue by using the quantitative computed tomography (QCT) in Chinese population
- (2018) X Cheng et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
- (2018) Milton Packer JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis
- (2018) Thomas A. Treibel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
- (2017) Shusuke Yagi et al. Diabetology & Metabolic Syndrome
- SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
- (2017) Liang Xu et al. EBioMedicine
- Increased Epicardial Adipose Tissue Volume Correlates With Cardiac Sympathetic Denervation in Patients With Heart FailureNovelty and Significance
- (2016) Valentina Parisi et al. CIRCULATION RESEARCH
- Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction
- (2012) Sabrina Greulich et al. CIRCULATION
- Predictors of New-Onset Heart Failure
- (2012) Jennifer E. Ho et al. Circulation-Heart Failure
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started